The predictors that are routinely used in selection of patients for treatment are a combination of the data from the study of the subpopulation composition of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in combination with the level of expression of the CTLA-4 and PD-1/PD-L1 checkpoints. Here, CTLA4 is linked to neoplasm.